EMBC Live signals | Maximize Profits with Getagraph.com

BUY 102762 min ago

@ $14.75

Issued: 14 Feb 2024 @ 13:48

Return: -29.49%

Previous signal: Feb 14 - 11:25

Previous signal: Sell

Return: 0.20 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes...

Stats
Today's Volume	487 110
Average Volume	435 724
Market Cap	598.82M
EPS	$0.590 ( 2024-02-09 )
Next earnings date	( $0.430 ) 2024-05-10
Last Dividend	$0.150 ( 2023-12-01 )
Next Dividend	$0 ( N/A )
P/E	10.83
ATR14	$0.0100 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2022-04-01	Reidy Christopher R	Sell	0	Common Stock
2022-04-01	Melcher David F	Sell	0	Common Stock
2024-04-04	Kurdikar Devdatt	Sell	4 535	Common Stock
2024-02-11	Kurdikar Devdatt	Sell	17 165	Common Stock
2024-02-12	Melcher David F	Buy	2 000	Common Stock

INSIDER POWER
77.59
Last 100 transactions
Buy: 2 135 787 \| Sell: 79 609

Volume Correlation

Long: -0.15 (neutral)

Short: 0.88 (strong)

Signal:(35.94) Same movement expected

Embecta Corp. Correlation

10 Most Positive Correlations
RMRM	0.938
ONEM	0.898
KPRX	0.884
GAINL	0.88
BLTE	0.879
QTEK	0.868
EMKR	0.862
CYRN	0.86
ONCR	0.859
TLGT	0.856

10 Most Negative Correlations
AMPH	-0.904
UFPT	-0.885
ABEO	-0.875
NVDA	-0.875
PETQ	-0.874
SDGR	-0.873
ALSK	-0.871
PCYG	-0.87
HGBL	-0.868
QQQM	-0.868

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Embecta Corp. Correlation - Currency/Commodity

-0.37
( neutral )

-0.53
( weak negative )

0.00
( neutral )

-0.64
( weak negative )

0.00
( neutral )

-0.41
( neutral )

Embecta Corp. Financials

Annual	2023
Revenue:	$1.12B
Gross Profit:	$749.90M (66.91 %)
EPS:	$1.230

Q1	2024
Revenue:	$277.30M
Gross Profit:	$185.90M (67.04 %)
EPS:	$0.350

Q4	2023
Revenue:	$281.90M
Gross Profit:	$181.80M (64.49 %)
EPS:	$0.100

Q3	2023
Revenue:	$286.10M
Gross Profit:	$189.50M (66.24 %)
EPS:	$0.270

Financial Reports:

No articles found.

Embecta Corp. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Embecta Corp. Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.97 - low (65.10%) | Divividend Growth Potential Score: 0.959 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2022-08-25
Last Dividend	$0.150	2023-12-01
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$0.900	--
Avg. Dividend % Per Year	0.90%	--
Score	2.81	--
Div. Sustainability Score	4.97
Div.Growth Potential Score	0.959
Div. Directional Score	2.97	--

Next Divdend (Est)
(2024-07-01)

$0.152 Estimate 36.00 %

Dividend Stability

0.72 Good

Dividend Score

2.81

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2022	$0.300	0.64%
2023	$0.600	2.37%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0493	1.500	9.01	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0454	1.200	8.49	10.00	[0 - 0.3]
returnOnEquityTTM	-0.0681	1.500	-1.868	-2.80	[0.1 - 1]
payoutRatioTTM	0.778	-1.000	2.22	-2.22	[0 - 1]
currentRatioTTM	2.20	0.800	3.99	3.19	[1 - 3]
quickRatioTTM	1.547	0.800	5.61	4.49	[0.8 - 2.5]
cashRatioTTM	0.915	1.500	6.03	9.05	[0.2 - 2]
debtRatioTTM	1.344	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	1.633	1.000	-0.506	-0.506	[3 - 30]
operatingCashFlowPerShareTTM	-0.101	2.00	-0.0336	-0.0673	[0 - 30]
freeCashFlowPerShareTTM	-0.527	2.00	-0.264	-0.527	[0 - 20]
debtEquityRatioTTM	-2.06	-1.500	-8.25	10.00	[0 - 2.5]
grossProfitMarginTTM	0.666	1.000	2.24	2.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.159	1.000	8.82	8.82	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.00354	1.000	-1.131	-1.131	[0.2 - 2]
assetTurnoverTTM	0.922	0.800	7.19	5.75	[0.5 - 2]
Total Score				4.97

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.32	1.000	8.96	0	[1 - 100]
returnOnEquityTTM	-0.0681	2.50	-1.201	-2.80	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.527	2.00	-0.176	-0.527	[0 - 30]
dividendYielPercentageTTM	5.51	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.101	2.00	-0.0336	-0.0673	[0 - 30]
payoutRatioTTM	0.778	1.500	2.22	-2.22	[0 - 1]
pegRatioTTM	-0.165	1.500	-4.43	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.00517	1.000	-2.63	0	[0.1 - 0.5]
Total Score				0.959

Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.